The estimated Net Worth of Charles B Haaser is at least $259 Thousand dollars as of 3 December 2021. Mr. Haaser owns over 2,400 units of Yield10 Bioscience Inc stock worth over $7,523 and over the last 21 years he sold YTEN stock worth over $0. In addition, he makes $251,942 as Chief Accounting Officer and Vice President - Finance at Yield10 Bioscience Inc.
Sign up
Mr. Haaser YTEN stock SEC Form 4 insiders trading
Charles has made over 3 trades of the Yield10 Bioscience Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently he bought 2,400 units of YTEN stock worth $10,080 on 3 December 2021.
The largest trade he's ever made was exercising 5,000 units of Yield10 Bioscience Inc stock on 8 February 2006 worth over $24,200. On average, Charles trades about 330 units every 214 days since 2003. As of 3 December 2021 he still owns at least 6,839 units of Yield10 Bioscience Inc stock.
You can see the complete history of Mr. Haaser stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Charles Haaser biography
Charles B. Haaser is a Chief Accounting Officer, Vice President - Finance of the Company. Mr. Haaser became the Company's Chief Accounting Officer effective November 3, 2014, after serving as the Company’s Corporate Controller since 2008. Mr. Haaser has more than thirty years of experience in accounting and finance, primarily working for publicly traded U.S. companies. Before joining Metabolix, Mr. Haaser was the Corporate Controller of Indevus Pharmaceuticals, Inc. from 2006 to 2008. He was the Corporate Controller and Principal Accounting Officer at ABIOMED, Inc. from 1998 to 2006 and additionally served as ABIOMED’s Acting Chief Financial Officer from 2003 to 2006. From 1997 to 1998 Mr. Haaser was controller for Technical Communications Corporation and from 1986 to 1997 was the Director of Finance at ISI Systems, Inc. From 1984 to 1986 Mr. Haaser was an auditor in the commercial audit division of Price Waterhouse LLP (now PricewaterhouseCoopers LLP). Mr. Haaser received a bachelor’s degree in business administration (finance) from the University of Notre Dame, an MBA from Northeastern University and a Masters of Science in Taxation from Bentley University. Mr. Haaser became a Certified Public Accountant in 1997.
What is the salary of Charles Haaser?
As the Chief Accounting Officer and Vice President - Finance of Yield10 Bioscience Inc, the total compensation of Charles Haaser at Yield10 Bioscience Inc is $251,942. There are 3 executives at Yield10 Bioscience Inc getting paid more, with Joseph Shaulson having the highest compensation of $1,394,220.
How old is Charles Haaser?
Charles Haaser is 60, he's been the Chief Accounting Officer and Vice President - Finance of Yield10 Bioscience Inc since 2016. There are 3 older and 4 younger executives at Yield10 Bioscience Inc. The oldest executive at Yield10 Bioscience Inc is Anthony Sinskey, 77, who is the Independent Director.
What's Charles Haaser's mailing address?
Charles's mailing address filed with the SEC is C/O YIELD10 BIOSCIENCE, INC., 19 PRESIDENTIAL WAY, SUITE 201, WOBURN, MA, 01801.
Insiders trading at Yield10 Bioscience Inc
Over the last 8 years, insiders at Yield10 Bioscience Inc have traded over $1,212,006 worth of Yield10 Bioscience Inc stock and bought 4,271,174 units worth $10,113,836 . The most active insiders traders include Jack W Schuler, Peter N Kellogg, and Joseph H Shaulson. On average, Yield10 Bioscience Inc executives and independent directors trade stock every 107 days with the average trade being worth of $238,638. The most recent stock trade was executed by Jack W Schuler on 20 December 2023, trading 36,000 units of YTEN stock currently worth $7,200.
What does Yield10 Bioscience Inc do?
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
What does Yield10 Bioscience Inc's logo look like?
Complete history of Mr. Haaser stock trades at Abiomed and Yield10 Bioscience Inc
Yield10 Bioscience Inc executives and stock owners
Yield10 Bioscience Inc executives and other stock owners filed with the SEC include:
-
Joseph Shaulson,
Director -
Oliver Peoples,
President, Chief Executive Officer, Director -
Lynne Brum,
Vice President - Planning and Communications -
Charles Haaser,
Chief Accounting Officer, Vice President - Finance -
Anthony Sinskey,
Independent Director -
Richard Hamilton,
Director -
Sherri Brown,
Director -
Sarah Cecil,
General Counsel, Secretary -
Kristi Snell,
Chief Science Officer, Vice President - Research -
Robert Van Nostrand,
Chairman of the Board, Independent Director -
Peter N Kellogg,
Director -
Jack W Schuler,
-
Willie Loh,
Director